PET Measurements of cAMP-Mediated Phosphodiesterase-4 with (R)-[11C]Rolipram
Miran Kenk(Centre for Addiction and Mental Health), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), Rob deKemp(University of Ottawa), Rob Beanlands(University of Ottawa), Adam J. Thomas(National University Heart Centre Singapore), Mireille Lortie(University of Ottawa)
Cited by 12
Related Papers
Impaired Myocardial Flow Reserve on Rubidium-82 Positron Emission Tomography Imaging Predicts Adverse Outcomes in Patients Assessed for Myocardial Ischemia
|Journal of the American College of Cardiology|2011|602
Anatomic Versus Physiologic Assessment of Coronary Artery Disease
|Journal of the American College of Cardiology|2013|563
The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512
F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease
|Journal of the American College of Cardiology|2007|476
Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease?
|Journal of Nuclear Cardiology|2012|303